ZDHHC9 and breast cancer: We observed that Imatinib alone impeded BC cell growth, and notably, Imatinib may indirectly impair the palmitoylation of ZDHHC9’s substrates, such as AKT and PD-L1, thus phenocopying a direct ZDHHC9 inhibitor.